Patents by Inventor Won-min Yoo

Won-min Yoo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent for reduction of scar formation by using wound alkalinization
    Patent number: 7255883
    Abstract: The present invention relates to an agent for reducing scar formation, which inhibits the scar formation by injecting sodium bicarbonate to the dermis tissue of the wound with a syringe to directly control pH of the wound site, namely, by alkalinizing the wound to inactivate TGF-?. According to the present invention, the agent for reducing scar formation by controlling the wound healing process can be clinically and immediately applied to the treatment of tylosis scar and keloid, etc., and is effective to the treatment of intractable fibrosis diseases. Also, the invention can be widely applied in many ways as an easy tool which can control the action of TGF-? in a living organism.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: August 14, 2007
    Assignee: Healagenics, Inc.
    Inventors: Ki Chang Keum, Naechoon Yoo, Won-min Yoo
  • Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
    Publication number: 20050142208
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of wounds containing blood plasma or serum and a method for treating wounds effectively by applying said composition to the wound site to normalize the tissue-environment around the site.
    Type: Application
    Filed: May 9, 2003
    Publication date: June 30, 2005
    Inventors: Won Min Yoo, Kyung Chang, Nae Yoo, Ki Keum, Sang Lee, Gene Lee
  • Agent for reduction of scar formation by using wound alkalinization
    Publication number: 20050136126
    Abstract: The present invention relates to an agent for reducing scar formation, which inhibits the scar formation by injecting sodium bicarbonate to the dermis tissue of the wound with a syringe to directly control pH of the wound site, namely, by alkalinizing the wound to inactivate TGF-?. According to the present invention, the agent for reducing scar formation by controlling the wound healing process can be clinically and immediately applied to the treatment of tylosis scar and keloid, etc., and is effective to the treatment of intractable fibrosis diseases. Also, the invention can be widely applied in many ways as an easy tool which can control the action of TGF-? in a living organism.
    Type: Application
    Filed: January 3, 2005
    Publication date: June 23, 2005
    Inventors: Ki Keum, Naechoon Yoo, Won-min Yoo
  • Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
    Publication number: 20040247562
    Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
    Type: Application
    Filed: March 22, 2004
    Publication date: December 9, 2004
    Inventors: Sang Yup Lee, Nae Choon Yoo, So Young Yoo, Hyun Cheol Chung, Ki Chang Keum, Won Min Yoo, Ki Jun Jeong
  • Agent for reduction of scar formation by using wound alkalinization
    Publication number: 20030180390
    Abstract: The present invention relates to an agent for reducing scar formation, which inhibits the scar formation by injecting sodium bicarbonate to the dermis tissue of the wound with a syringe to directly control pH of the wound site, namely, by alkalinizing the wound to inactivate TGF-&bgr;. According to the present invention, the agent for reducing scar formation by controlling the wound healing process can be clinically and immediately applied to the treatment of tylosis scar and keloid, etc., and is effective to the treatment of intractable fibrosis diseases. Also, the invention can be widely applied in many ways as an easy tool which can control the action of TGF-&bgr; in a living organism.
    Type: Application
    Filed: March 17, 2003
    Publication date: September 25, 2003
    Inventors: Ki Chang Keum, Naechoon Yoo, Won-min Yoo